Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Pr...

Por Kahn, Steven E., Haffner, Steven M., Viberti, Giancarlo, Herman, William H., Lachin, John M., Kravitz, Barbara G., Yu, Dahong, Paul, Gitanjali, Holman, Rury R., Zinman, Bernard
Publicado em 2010

Renal Function in Type 2 Diabetes with Rosiglitazone, Metformin, and Glyburide Monotherapy

Por Lachin, John M., Viberti, Giancarlo, Zinman, Bernard, Haffner, Steven M., Aftring, R. Paul, Paul, Gitanjali, Kravitz, Barbara G., Herman, William H., Holman, Rury R., Kahn, Steven E.
Publicado em 2011

Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT

Por Kahn, Steven E., Lachin, John M., Zinman, Bernard, Haffner, Steven M., Aftring, R. Paul, Paul, Gitanjali, Kravitz, Barbara G., Herman, William H., Viberti, Giancarlo, Holman, Rury R.
Publicado em 2011

Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristic...

Por Fitzpatrick, Lorraine A., Bilezikian, John P., Wooddell, Margaret, Paul, Gitanjali, Kolatkar, Nikheel S., Nino, Antonio J., Miller, Colin G., Bogado, Cesar E., Arnaud, Claude D., Cobitz, Alexander R.
Publicado no J Drug Assess (2011)